Baird Medical Investment Holdings (BDMD) Income towards Parent Company (2025)
Baird Medical Investment Holdings (BDMD) posted quarterly Income towards Parent Company of $65232.0 for Q2 2025.
Baird Medical Investment Holdings (BDMD) Income towards Parent Company (2025) Analysis & Trends
Baird Medical Investment Holdings (BDMD) has reported Income towards Parent Company for 1 consecutive years, with $65232.0 the latest figure, recorded in Q2 2025.
- In Q2 2025, Income towards Parent Company changed N/A year-over-year to $65232.0; the TTM figure through Jun 2025 stood at $65232.0 (changed N/A YoY), while the FY2025 annual figure was -$19.8 million, down 258.74% from the prior year.
- Income towards Parent Company was little changed at $65232.0 in Q2 2025 per BDMD's latest filing.
- Across five years, Income towards Parent Company topped out at $65232.0 in Q2 2025 and bottomed at $65232.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn |
| 10 | Baird Medical Investment Holdings | 32.67 Mn | 32.28 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 65,232.00 |